呈和科技(688625)2025年三季报点评：国产替代与海外扩张支撑公司稳健增长

Core Insights - The company reported a revenue of 740 million yuan for Q3 2025, representing a year-on-year growth of 14.16%, and a net profit attributable to shareholders of 228 million yuan, up 15.09% year-on-year [1][2]. Financial Performance - In Q3 2025, the company achieved a single-quarter revenue of 269 million yuan, which is a 14.84% increase compared to the same period last year, and a net profit of 80.54 million yuan, reflecting a year-on-year growth of 14.66% [2]. - The company has experienced three consecutive quarters of sequential profit growth [2]. Growth Drivers - The growth is primarily driven by breakthroughs in overseas markets for core products, namely nucleating agents and synthetic hydrotalcite [2]. - For the first three quarters of 2025, overseas revenue growth remained above 30%, with a remarkable 70% growth in the first half of the year [2]. - Key growth regions include the Middle East, Europe, and Southeast Asia [2]. Capacity Expansion and Market Strategy - The company has resolved its production capacity bottleneck with the official launch of the Nansha factory in Q1 2025, planning to exceed an annual capacity of 10,000 tons [3]. - The operational model has shifted from "capacity-driven" to "order-driven," ensuring robust support for new domestic and international demand [3]. - The company has secured orders from major global clients, including Bayer, for synthetic hydrotalcite, which is expected to become a new growth engine following nucleating agents [3]. Market Expansion - The company is actively exploring untapped markets in South America and the CIS, having already secured orders in the CIS region, indicating significant future growth potential in overseas markets [3]. Investment Outlook - The company is positioned as a leading domestic player in nucleating agents and synthetic hydrotalcite, with expectations for gradual release of production and sales as the replacement process and customer development progress. Projected EPS for 2025-2027 are 1.49 yuan, 1.75 yuan, and 2.08 yuan respectively [3].